Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alkem Laboratories Ltd

NSE: ALKEM · BSE: 539523 · Pharmaceuticals & Biotechnology · 49 announcements

Alkem Laboratories Ltd news stories on ALFA NewsRead the news →
Share price
₹5,350.50
Market cap
₹63,973 Cr
Revenue (annual)
₹14,712 Cr
Net profit (annual)
₹2,302 Cr
P/E (TTM)
29.6×Sector 47.3×
Promoter holding
49.70%-1.50% QoQ
FII holding
10.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:08 IST NSE
Legal & Regulatory

Alkem Laboratories Legal & Regulatory

Alkem Laboratories received favorable CIT(A) orders for assessment years 2018-2023. The ruling deletes tax disallowances totaling Rs. 660.77 Crore, providing significant regulatory relief.

Value
₹660.8 Cr
16:48 IST NSE
Legal & Regulatory

Alkem Laboratories Legal & Regulatory

Alkem Laboratories received favourable tax orders from CIT(A) for AY 2018-2023. The orders involve a tax amount of ₹60.77 Crore.

Value
₹60.77 Cr
18:48 IST NSE
Legal & Regulatory

Alkem Laboratories Legal & Regulatory

Alkem Laboratories Limited received a favorable order dropping a GST demand of ₹69.66 Crore, including interest and penalties. The order from Mumbai GST authorities relates to alleged incorrect ITC/refund claims. The company stated there is no material impact on its financial or operational activities.

Value
₹69.66 Cr
16:36 IST BSE
Legal & Regulatory

Alkem Laboratories Legal & Regulatory

Alkem Laboratories received an income tax assessment order for AY 2023-24 with a disputed tax amount of ₹333.38 Crore. The dispute relates to 80IE deduction disallowance and transfer pricing adjustments. The company states no cash outflow is expected due to MAT credit utilization and plans to appeal the order.

Value
₹333.4 Cr